Elicio Therapeutics raises $10M in registered direct offering of shares and warrants

Elicio Therapeutics, Inc.

Gross proceeds of $10.0M from sale of 1,261,830 shares and warrants priced at $7.925 per unit.
Warrants exercisable at $7.80/share for five years, immediately exercisable with 4.99% ownership blocker.
H.C. Wainwright & Co. acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
Offering closed on January 30, 2025 under effective shelf registration statement (File No. 333-279925).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.